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EFFECT OF VITAMIN D ON GLOBAL DNA METHYLATION 
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ABSTRACT 
Problem: Vitamin D deficiency has been linked to increased risks of hypertension, 
multiple sclerosis, cardiovascular diseases, and various forms of cancer. Studies have 
investigated the role of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) and vitamin D status on 
epigenetics of specific genes. However, there has not been any investigation on the direct 
relationship between vitamin D status and global DNA methylation. This study attempted 
to examine that relationship. 
Method: Subjects were recruited with flyers around the Boston University 
Medical (BUMC) campus. Subjects’ blood was drawn at the General Clinical Research 
Unit (GCRU). Serum was isolated from whole blood by centrifugation. Buffy coat was 
isolated from whole blood with Accuspin System Histopaque-1077 tubes from Sigma-
Aldrich. DNA was isolated from buffy coat with AllPrep DNA/RNA Mini prep from 
Qiagen. Subject’s serum 25(OH)D concentration was measured with automated IDS-
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iSYS system, and their percent DNA methylation was measured by high performance 
liquid chromatography (HPLC). 
Results: The mean serum 25(OH)D concentration of five subjects was 32.9ng/mL. 
The mean percent cytosine methylation was 4.7% with standard deviation of 0.2%. One 
subject was vitamin D deficient, and the remaining four subjects were vitamin D 
sufficient. The vitamin D deficient subject had a percent cytosine methylation of 4.3%. 
The mean percent cytosine methylation of vitamin D sufficient subjects was 4.8% with 
standard deviation of 0.1%. 
Conclusions: The percent cytosine methylation of the vitamin D deficient subject 
was lower than the mean percent cytosine methylation of four vitamin D sufficient 
subjects. This data suggests that there is a possible correlation between vitamin D status 
and global DNA methylation. However, a larger sample size is needed to make any 
conclusions for the study. 
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INTRODUCTION 
Vitamin D 
Vitamin D came into existence approximately 750 million years ago in 
phytoplankton (Holick, 1989). Even though vitamin D is an ancient hormone, its 
importance in human biology only became apparent during the twentieth century. The 
onset of industrialization in Northern Europe generated heavy pollution and clustered 
housing, and created a living environment rife with sun deprivation. This caused a 
prevalence of rickets, a bone-deforming disease in children. Physicians realized that 
rickets can be cured by exposure to a mercury arc lamp (Huldschinsky, 1919). 
Ultimately, scientists determined vitamin D to be vital for bone health and prevention of 
rickets, osteopenia, and osteomalacia (Holick, 2007). 
Humans obtain vitamin D through diet or sun exposure (Holick, 1989). When 
ultraviolet B (UVB) radiation penetrates human skin, vitamin D3 precursor 
7-dehydrocholesterol (7-DHC) converts to previtamin D3, which quickly converts to 
vitamin D3 (Holick, 2007). In yeast and fungi, UV radiation converts vitamin D2 
precursor ergosterol to vitamin D2 (Rajakumar, Greenspan, Thomas, & Holick, 2007). 
Vitamin D3 and vitamin D2 can also be obtained through fish, fortified foods, or 
supplements (Holick, 2006b). In order to become biologically active, vitamin D 
undergoes two hydroxylation reactions (Holick, 2007). The first hydroxylation converts 
vitamin D to 25-hydroxyvitamin D (25(OH)D) in the liver (Holick, 2008). The second 
hydroxylation step metabolizes 25(OH)D to 1,25-dihydroxyvitamin D (1,25(OH)D) by 
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25-hydroxyvitamin D-1α-hydroxylase in the kidney (Holick, 2006a). 1,25(OH)2D is the 
biological active form of vitamin D (Holick et al, 1971). The enzyme 25-hydroxyvitamin 
D-24-hydroxylase (CYP24) catabolizes 1,25(OH)2D  into biologically inert, water 
soluble metabolite calcitroic acid (Holick, 2007). Calcitroic acid is eventually excreted as 
bile (Holick, 2006). Renal production of 1,25(OH)2D is heavily regulated by parathyroid 
hormone, serum calcium, phosphorus concentration, fibroblast growth factor 23, and 
1,25(OH)2D (Holick, 2006). 
 
Figure 1: Metabolism of Vitamin D3.  Figure is taken from Holick, 2007. Vitamin D3 needs to 
undergo two hydroxylation to become biologically active as 1,25(OH)2D3. 
 
1,25(OH)2D is crucial for bone health and maintenance of blood calcium and 
phosphorus. Increase vitamin D status will increase intestinal reabsorption of calcium by 
65% and phosphorus by 80% (Heaney, Dowell, Hale, & Bendich, 2003). Decrease in 
blood calcium is recognized by a calcium sensor in the parathyroid glands, which will 
increase the secretion of parathyroid hormone (PTH) (Holick, 2006). Vitamin D 
deficiency can cause secondary hyperparathyroidism and exacerbate osteoporosis 
(Holick, 2004, p. 1).  When 1,25(OH)2D binds to the vitamin D receptor (VDR) within 
osteoblasts, it increases expression of the receptor activator of nuclear factor kappa-B 
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ligand (RANKL) (Holick, 2006). RANKL binds to its receptor activator of nuclear factor 
kappa-B (RANK) on preosteoclasts and stimulates the maturation of preosteoclasts to 
osteoclasts (Holick, 2006). Osteoclasts promote the releases free calcium and phosphorus 
stored in the bone to the blood stream. 
Serum 25(OH)D concentration determines a patient’s vitamin D status as 
deficient, insufficient, and sufficient (Holick, 2009). Serum 25(OH)D concentration 
consists of circulating 25(OH)D3 and circulating 25(OH)D2. Although 1,25(OH)2D is the 
active form of vitamin D, its circulating concentration gives a false representation of the 
overall picture (Holick, 2009). Vitamin D deficient subjects may have normal or even 
elevated plasma 1,25(OH)2D  concentrations (Holick, 2004b). This contradiction occurs 
for several reasons. First, 1,25(OH)2D  has a half-life of 4-6 hours and 25(OH)D has a 
half-life of 2-3 weeks (Holick, 2009). Second, circulating 1,25(OH)2D concentrations are 
1000 fold less than circulating 25(OH)D concentrations (Holick, 2004b). And finally, 
vitamin D deficiency decreases intestinal absorption of calcium from 30%-40% to 10%-
15% (Heaney et al., 2003). The decrease in calcium concentration causes an increase 
production of PTH; PTH restores blood calcium concentrations by increasing tubule 
reabsorption of calcium in the kidney and mobilizing of calcium from bone (Holick, 
2009). This may cause detrimental and long-term effects to bone health. Furthermore 
PTH stimulates the kidney to increase production of 1,25(OH)2D (Holick, 2004b). Thus, 
serum 1,25(OH)2D concentrations may be increased in severely vitamin D deficient 
people. 
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Circulating plasma 25(OH)D concentration reflects vitamin D production from 
sun exposure and dietary vitamin D intake (Holick, 2009). Experts generally agree that 
serum 25(OH)D levels less than 20 ng per milliliter constitutes vitamin D deficiency 
(Holick, 2007). Vitamin D insufficiency is serum 25(OH)D concentration of 21 to 29 ng 
per milliliter (Holick, 2009). Vitamin D sufficiency is serum 25(OH)D concentration 
more than 30ng/mL. Using these definitions, approximately one billion people are 
vitamin D deficient or insufficient (Holick, 2006). 
1,25(OH)2D has myriad of effects throughout the body. 1,25(OH)2D affects 
hundreds of genes through its interactions with the vitamin D receptor (VDR) (Nagpal et 
al., 2005). Once 1,25(OH)2D enters the cell, it binds to VDR in the cytoplasm 
(Nishikawa, Kitaura, Matsumoto, Imagawa, & Nishihara, 1994). VDR-1,25(OH)2D3 
binds to retinoid X receptor (RXR) and translocate into the nucleus (Cheskis & 
Freedman, 1994). VDR binds to vitamin D response elements (VDREs), which are on the 
promoters of responsive genes (Nagpal et al., 2005). After binding to VDREs of 
responsive genes, VDR up-regulates or down-regulates various genes. VDR has been 
found in cells such as intestine, bone, kidney, parathyroid gland cells, colon cells, ovarian 
cells, and lymphocytes (Nagpal et al., 2005). 
Subsequently, vitamin D deficiency has diverse and extensive consequences. For 
example, skeletal muscle has VDR; vitamin D deficiency causes muscle weakness 
(Holick, 2007). Furthermore, increase in vitamin D status correlates with an increase in 
muscle strength and speed performance (Holick, 2007).  Vitamin D deficiency has been 
5 
 
associated with increased risk of type 1 diabetes, multiple sclerosis, Crohn’s disease, 
rheumatoid arthritis, osteoarthritis, cardiovascular diseases, and cancer, as well as 
increased incidences of schizophrenia and depression (Holick, 2007). 
1,25(OH)2D3 regulates cell differentiation, apoptosis, proliferation and 
angiogenesis in tumor cells (Pereira, Larriba, & Muñoz, 2012). Epidemiology studies 
show that vitamin D deficiencies increase risk of various forms of cancer such as breast, 
prostate, and colorectal (Holick, 2003). Women with less than 12 ng/mL of 25(OH)D 
increase the risk of developing colorectal cancer by 253% compared to women with 
normal baseline 25(OH)D (Holick, 2003). 1,25(OH)2D3 reduces the development of 
squamous cell carcinoma, leukemia, breast, colon, and colorectal cancer (Nagpal et al., 
2005). 
The effects of vitamin D have been implicated in a broad range of diseases and 
disorders. Many investigations are underway to elucidate the mechanisms of the effects 
of vitamin D. Recent studies have proposed an epigenetic approach. 
Epigenetics: 
Epigenetics is the study of heritable alteration of gene expression caused by 
reasons other than changes in underlying deoxyribonucleic acid (DNA) genome (Berger, 
Kouzarides, Shiekhattar, & Shilatifard, 2009). In 2006, there have been more than 2,500 
articles published regarding epigenetics (Bird, 2007). The fascination with epigenetics 
continues to grow and capture the imagination of scientists as well as the general public. 
It contradicts the notion that who we are is predetermined by our DNA. The air we 
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breathe, the food we eat, and the microcosm of our individual environment all contribute 
and coalesce to our overall gene expression. Monozygotic twins are epigenetically 
indistinguishable at the beginning of life, but they become significantly dissimilar in 
DNA methylation and histone acetylation later in life (Fraga et al., 2005). Epigenetic 
inheritance is the dynamic variable that interlinks our internal genetic expression with our 
individual experiences and environments.  
Epigenetic mechanisms involve covalent changes to DNA methylation, histone 
modification, and genetic imprinting (Hatziapostolou & Iliopoulos, 2011). These three 
actions are inter-related and often work together to alter gene expression (Hatziapostolou 
& Iliopoulos, 2011). 
Epigenetic paradigm contains two classical mechanisms: DNA methylation and 
the Polycomb (Pc) and Trithorax (TrxG) systems (Bird, 2007). DNA methylation adds an 
additional methyl group at the 5 position of a cytosine nucleotide in cytosine guanine 
dinucleotide (CpG) by DNA methyltransferase (DNMTs). CpG islands are regions with 
high content of CpG repeats greater than 200 base pair. CpG islands are associated with 
approximately 60% of all human genes (Antequera & Bird, 1993). Most CpG islands are 
not methylated in normal tissues (Hatziapostolou & Iliopoulos, 2011).  The total amount 
of methylated cytosine accounts for approximately only one percent of total DNA bases 
(Bird, 2002). DNA methylation favors the condensed chromatin state and hinders gene 
transcription (Hatziapostolou & Iliopoulos, 2011). This can be accomplished by two 
mechanisms: first, DNA methylation can prevent DNA-binding factor from recognizing 
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promoter sequences; and second, proteins that recognize specific DNA methylation 
patterns suppress gene transcription and modify chromatin structure (Klose & Bird, 
2006). 
Although totally methylated cytosine is approximately one percent in adult 
humans, the amount of DNA methylation varies drastically during development. DNA 
methylation starts as early as germ-cell development. During embryo differentiation, 
DNA methylation becomes established and heritable in various somatic cell lineages 
(Green & Sambrook, 2012). Demethylation occurs throughout development and becomes 
complete at birth (Green & Sambrook, 2012). DNA methylation mediates gene silencing 
occurs throughout the genome, and it determines genomic imprinting and X-chromosome 
inactivation. Genetic imprinting silences genes in a parent-of-origin specific manner. It is 
independent of Mendelian inheritance, and imprinted genes are silenced while the non-
imprinted gene is expressed.  Investigation in the 1980’s showed that the use of 
5-aza-2’-deoxycytidine, an inhibitor of DNA methylation, can reactivate the inactive X 
chromosome (Mohandas, Sparkes, & Shapiro, 1981). Thus, proper DNA methylation is 
vital for development. 
The Polycomb (Pc) and Trithorax (TrxG) are groups of proteins that activate or 
repress transcription states (Bird, 2007). They first came into prominence in research in 
cellular memory. Drosophila melanogaster embryos with Pc mutation accurately 
expressed genes that specified different body segments of the fruit fly (Kennison, 1995). 
However, this information could not be passed onto the daughter cells and cellular 
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memory was not maintained (Kennison, 1995). These embryos developed into adult fruit 
flies with legs in place of antennas (Kennison, 1995). Further investigation demonstrated 
that Pc proteins repressed inappropriate gene activation in order to progress with normal 
development (Schuettengruber, Chourrout, Vervoort, Leblanc, & Cavalli, 2007). 
Polycomb group (PcG) proteins keep chromatin in an “off” state to inhibit gene 
expression. Conversely, trithorax group (TrxG) proteins activate gene expression by 
keeping the chromatin in an “on” state (Mills, 2010). PcG and TrxG proteins work 
together to regulate chromatin dynamic, and ultimately gene expression. 
One mechanism of PcG and TrxG regulation of chromatin is by histone 
modification. Modifications to the amino-terminal tail of histones at specific residues 
include methylation, acetylation, phosphorylation, ubquitylation, and ADP-ribosylation 
(Mills, 2010). Unique combinations of these modifications determine chromatin 
dynamic; they generally alter the ability of chromatin readers to bind to nucleosomes 
(Mills, 2010). For example, PcG and TrxG proteins both determine histone modification, 
but they can methylate different residues and can produce diverse biological effects. 
Epigenetic inheritance permeates into diverse aspects of development and 
physiology. For example, a study in rats showed that maternal behavior can alter the 
epigenome of the rat offspring (Weaver et al., 2004). Increased grooming and licking by 
the rat mother produced greater DNA methylation of the glucocorticoid receptor (GR) 
gene promoter in the hippocampus (Weaver et al., 2004). Epigenetic changes to GR alter 
the rat offspring hypothalamic-pituitary-adrenal responses to stress; this study suggests a 
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causal relationship of maternal behavior to offspring stress response (Weaver et al., 
2004). In another study, changes in DNA methylation have been associated with memory 
formation in rats (Miller & Sweatt, 2007). DNMTs catalyze DNA methylation; DNMT’s 
are up-regulated during memory formation (Miller & Sweatt, 2007). Furthermore, 
epigenetic changes are required for activation of T-lymphocytes (Bruniquel & Schwartz, 
2003). One study showed that activation of T lymphocytes required demethylation of the 
promoter-enhancer of interleukin-2 gene (Bruniquel & Schwartz, 2003). Epigenetic 
inheritance is vital for normal physiology. It is dynamic and heavily influenced by 
environmental factors. 
Predictably, epigenetic inheritance also plays an important role in the generation 
and progression of disease. Abnormal genomic imprinting of genes on 11p15 causes 
Beckwith-Wiedemann syndrome (Feinberg, 2007),  an epigenetic disease characterized 
by prenatal overgrowth, a midline abdominal wall, and increased risk of cancer 
(Feinberg, 2007). Abnormal genomic imprinting also cause Prader-Willi syndrome and 
Angelman syndrome (Horsthemke & Buiting, 2006). Studies have associated Rett 
syndrome and alpha-thalassaemia X-linked mental retardation syndrome to epigenetic 
inheritance (Gibbons & Higgs, 2000). Furthermore, abnormal epigenetic inheritance 
plays an important role in inception and progression of various types of cancer. 
The first detected epigenetic abnormality in cancer cells was global DNA 
hypomethylation (Feinberg & Vogelstein, 1983). Further investigation revealed that 
many cancer types contain global DNA hypomethylation and hypermethylation of tumor 
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suppressor gene promoters (Hatziapostolou & Iliopoulos, 2011). Global DNA 
hypomethylation can initiate cancer development because it causes chromosomal 
instability, gene reactivation, and loss of imprinting (Esteller, 2008). Hypomethylation of 
DNA of repeat sequences promotes mitotic recombination (Hatziapostolou & Iliopoulos, 
2011). Mitotic recombination can cause deletion and translocation of DNA, chromosomal 
rearrangement, and overall genomic instability (Hatziapostolou & Iliopoulos, 2011). In 
various cancers, such as ovarian and breast carcinomas, there are hypomethylation in the 
pericentromeric satellite sequences (Eden, Gaudet, Waghmare, & Jaenisch, 2003). This 
increases changes of breakage and recombination (Yeh et al., 2002). Global 
hypomethylation activate genes that are normally silenced due to methylation of CpG 
islands in the promoter region. For example, DNA hypomethylation can activate long 
interspersed nuclear element (L1) retrotransposon, which has the ability to translocate to 
other regions in the gene and cause genomic instability (Howard, Eiges, Gaudet, 
Jaenisch, & Eden, 2008). L1 reactivation is characteristic of colorectal cancer (Howard et 
al., 2008). Hypomethylation also reactivates normally suppressed human genes. 
Hypomethylation of cyclin D2 and maspin promoter creates overexpression of proteins in 
gastric carcinoma (Feinberg & Tycko, 2004). Similarly, hypomethylation generates 
increased gene expression of melanoma-associated antigen (MAGE) in melanoma, S100 
calcium-binding protein A4 (S100A4) in colon cancer, and human papillomavirus 1 
(HPV1) in cervical cancer (Hatziapostolou & Iliopoulos, 2011). 
Vitamin D and Epigenetics: 
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Recent studies have illustrated a dynamic relationship between vitamin D and 
epigenetic inheritance. 1,25(OH)2D3 is required for invariant natural killer T (iNKT) cell 
development in neonatal mice (Yu & Cantorna, 2011). In utero mice deficient in vitamin 
D have a drastic decrease in iNKT; furthermore, this effect cannot be reversed later on 
with vitamin D supplementation (Yu & Cantorna, 2011). Reduction of NKT cells 
increase chances of autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, 
and multiple sclerosis (Yu & Cantorna, 2011). Additionally, epigenetic mechanisms 
control the vitamin D pathway. CYP24 is under epigenetic control in the placenta 
(Novakovic et al., 2009) 
Vitamin D regulate gene expression by histone modifications. In control gene 
regulation VDR/RXR heterodimer interacts with histone acetyltransferases (HATs) to 
increase the availability of chromatin to transcription factors (Fujiki et al., 2005). HATs 
add acetyl groups to nucleosomes, which neutralizes the basicity of histones, and opens 
up the chromatin to transcription factors (Karlic & Varga, 2011). HAT’s are 
transcriptional activators. Furthermore, binding of VDR/RXR to negative vitamin D 
response elements (VDREs) such as nuclear receptor co-repressor (NCOR1) and 
silencing mediator for retinoic acid and thyroid hormone receptors (SMRT) recruits 
histone deacetylases to inactivate transcription (Karlic & Varga, 2011).  
1,25(OH)2D3 exerts its effects on human colon through epigenetic inheritance. 
1,25(OH)2D3 induces Jumonji C domain-containing protein 3 (JMJD3), a histone H3 
lysine demethylase that controls the phenotype of human colon cancer  (Pereira et al., 
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2011). Gene expression of VDR and JMJD3 are correlated during instances of human 
colon cancer; VDR expression controls the upregulation of JMJD3 (Pereira et al., 2011). 
Therefore, JMJD3 mediates the effect of 1,25(OH)2D3 on human colon.  
Additionally, serum 25(OH)D concentrations influence changes to DNA methylation. 
African-American adolescents that are vitamin D deficient, when compared to 
adolescents that are vitamin D sufficient, have methylation changes in leukocyte DNA 
(Zhu et al., 2012). These changes in methylation occurred for specific genes vital to 
vitamin D metabolism (Zhu et al., 2012). Moreover, subjects that were vitamin D 
deficient had a general decrease in methylation compared to subjects that were vitamin D 
sufficient (Zhu et al., 2012). Another study reported an inverse association between 
vitamin D status and risk of colorectal cancer (Rawson et al., 2012).  In colorectal cancer, 
the gene Dickkopt-related protein 1 (DKK1) is often hypermethylated and contribute to 
carcinogenesis. This study revealed that vitamin D intake in patients was negatively 
correlated with Dickkopt-related protein 1 (DKK1) promoter methylation (Rawson et al., 
2012). 
To date, there have been no reports of the effects of vitamin D status on global 
DNA methylation. Therefore, this study investigated the correlation between subject’s 
vitamin D status and percent cytosine methylation. 
Techniques for DNA Methylation Analysis: 
Isocratic reversed-phase HPLC can be used to measure quantities of individual 
deoxyribonucleotides (Ramsahoye, 2002). Enzymatic hydrolysis of genomic DNA with 
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deoxyribonuclease I (DNase I) and Nuclease P1 will hydrolyze the DNA to its 
deoxyribonucleotide components (Ramsahoye, 2002). The area under the peak will 
quantify the amount of different deoxyribonucleotides. 
Bisulfite reaction is the most common method for DNA methylation analysis 
(Green & Sambrook, 2012). DNA nucleotide cytosine is deaminated and becomes uracil 
with sodium bisulfite treatment. Methylated cytosine takes much longer to be 
deaminated. Deaminated DNA is amplified by polymerase chain reaction (PCR); the 
complimentary DNA pair will incorporate an adenosine to the deaminated cytosine. At 
the end, the original deaminated cytosine will be amplified to a thymine (Green & 
Sambrook, 2012). The product of the bisulfite reaction can be used for further analysis 
depending on the scale of the study. Product of bisulfite reaction can be used for 
methylation-specific PCR to detect gene specific DNA methylation (Green & Sambrook, 
2012), non-methylation specific PCR, and microarray. Methylation specific PCR 
provides the relative difference of CpG density in a specific genomic region (Green & 
Sambrook, 2012). 
There are antibodies that have the ability to specifically bind to methylated 
cytosine. These antibodies can form DNA fragments that are either heavily methylated or 
depleted of methylation. Afterwards, the methylated DNA fragments are concentrated for 
further analysis. Usually, immunoprecipitation proceeds with DNA microarray analysis 
or gene –specific methylation analysis, or deep sequencing (Green & Sambrook, 2012). 
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Restriction endonucleases are used for global analysis of DNA methylation. 
Various combination of endonucleases provide fractions of predominantly methylated or 
unmethylated compartments (Green & Sambrook, 2012). This method does not require 
bisulfite conversion products. 
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SPECIFIC AIM 
Vitamin D has diverse physiological effects. Vitamin D deficiency has been linked to 
increased risk to cardiovascular disease, hypertension, and multiple sclerosis. This study 
investigated the epigenetic effects of vitamin D status in healthy adults. One form of 
epigenetic control is DNA methylation. Global DNA hypomethylation causes 
chromosomal instability, gene reactivation, and loss of imprinting (Esteller, 2008). The 
aim of the study was to 
1. Determine the relationship of subject’s serum 25(OH)D concentrations and 
percent cytosine methylation by HPLC. 
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MATERIALS AND METHODS 
Recruiting: 
This project was approved by IRB with protocol number H-31208. Subjects were 
recruited by flyers posted throughout the BUMC campus. Subjects who expressed 
interest were screened for eligibility over the telephone. Once eligible, subjects visited 
the GCRU at Boston University Medical Center (BUMC) for enrollment. Subjects’ 
bloods were drawn into one 9mL red top blood collection tubes from BD Falcon and 
three 4mL green top plasma tubes with heparin from BD Falcon. Blood from red top tube 
was used to quantify the 25(OH)D level. Blood from green top tube was used to isolate 
DNA and RNA. 
Determination of Serum 25(OH)D: 
Blood from red top tube was centrifuged at 20 minutes at 20 C and 5,000 rpm. 
The samples separated into erythrocytes and serum. The erythrocytes were discarded and 
serum was used to analyze 25(OH)D concentration with Automated IDS-iSYS System 
(Immunodiagnostics Systems). 
Buffy Coat Extraction from whole blood: 
Subject’s blood was drawn into three 4mL green top tube treated with sodium 
heparin from BD Falcon to separate mononuclear cells from whole blood. Immediately 
afterwards, all three tubes of blood were poured into 50mL Accuspin System 
Histopaque-1077 tube. Accuspin tubes have two chambers separated by a porous high-
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density polyethylene barrier. The tubes were centrifuged at 5,000 rpm at 4 C for 25 min 
with no brake. Centrifugation differentiated the various portions of blood components. 
Erythrocytes and granulocytes formed a pellet at the bottom the Accuspin tube. 
Lymphocytes and other mononuclear cells (buffy coat) remained at the top of the 
high-density barrier. Buffy coat layer was pipetted out and transferred to a new 50mL 
conical tube from BD Falcon. The 50mL conical tube was filled to the top with wash 
buffer Dulbecco’s Phosphate-Buffered Saline from Life Technologies. The conical tube 
was centrifuged at 3000 rpm at 4 C for 25 minutes with no brake. The cells from buffy 
coat formed a pellet at the bottom of the conical tube. The supernatant was discarded. 
1.5mL of RNAlater RNA Stabilization Reagent was added to the cell pellet. The cell 
pellet was homogenized by pipetting up and down. Finally, the buffy coat was separated 
into two microcentrifuge tubes with 750 µL volume each. 
DNA Isolation from Buffy Coat: 
Buffy coat was centrifuged at 300g 5 minutes to obtain cell pellets. After 
centrifugation, supernatant was thrown out. DNA was isolated from buffy coat with 
Qiagen kit AllPrep DNA/RNA Miniprep kit. After the formation of buffy coat cell pellet, 
the supernatant was thrown out. Lysis buffer RLT from the miniprep was added to lyse 
the cells. The buffy coat samples were thoroughly vortexed to homogenize the samples. 
The homogenized sample was added to the DNA. DNA concentration was read using a 
NanoDrop Spectrophometer at the BUMC Analytical Instrumentation Core. 
DNA Hydrolysis: 
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The following protocol is a modification of Ramsahoye, 2002. Endonuclease 
DNase I and Nuclease P1 were used to hydrolyze genomic DNA into individual 
nucleotides. DNase I and Nuclease P1 enzymes were bought in powder form. DNase I 
was reconstituted in 0.15M NaCl to a working solution of 1mg/mL. Nuclease P1 was 
reconstituted in 20mM sodium acetate at pH 5.3, 5mM ZnCl2, and 50mM sodium 
chloride. To ensure a longer a shelf life of the enzyme, an equal amount of glycerol was 
added to the Nuclease P1 enzyme. The enzyme was stored at -20 C at a working solution 
of 0.65 mg/mL. 
First DNase I digested the whole genomic DNA into oligonucleotides. DNase I 
acted on phosphodiester bonds next to pyrimidines to create oligonucleotides with 
5’-phosphates. Nuclease P1 digests 3’-5’ phosphodiester bonds in single strand 
nucleotides. Nuclease P1 hydrolyzes the oligonucleotides to individual nucleotides. 
Genomic DNA was precipitated by adding 0.1 volume of 3M sodium acetate pH 
5.2 and 2.5 volume of 100% ethanol. The samples were centrifuged at 2000g to obtain a 
DNA pellet. The DNA was washed by adding 1.5mL of 70% ethanol and then 
centrifuging the samples at 2000g. The DNA was then dissolved in 100µL of a buffer 
that contained 10mM Tris-HCl, pH 7.2, 0.1 mM EDTA, and 4mM magnesium chloride 
(DNase I buffer). Approximately 10µL of DNase I, at working solution of 1mg/ml, was 
added for each DNA sample. The samples were incubated at 37 C for 20 min. 
After the first incubation, the samples were heated to 90
 
C for 10 min to break the 
hydrogen bonds of the double stranded DNA, leaving single stranded DNA. The single 
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stranded DNA was placed on ice for 2 min to prevent the reannealing of double stranded 
DNA.  Then 200µL of Nuclease P1 buffer, which consisted of 30mM sodium acetate, pH 
5.2 and 1.5mM zinc sulphate, was added to the DNA samples. 10µL Nuclease P1, 
working solution of 0.65mg/mL, was added to the DNA samples. The samples were 
incubated at 37 C for 20 min. After incubation, the samples were centrifuged with 0.45 
µm filter to remove solid debris. 
High Pressure Liquid Chromatography: 
DNA nucleotides were quantified using reverse-phase HPLC with Agilent 1100 
series. A ZORBAX 5µm ODS column that is 4.6 X 250mm from Agilent was used for 
solid phase and 50mM ammonium phosphoric acid, pH 4.1, for the mobile phase at a 
flow rate of 1mL/min. 50 mM ammonium phosphoric acid was made by dissolving 50 
mmol of diammonium orthophosphate (from Sigma-Aldrich) in 1L of water, and then pH 
was adjusted with orthophosphosphoric acid. Individual nucleotide, 2’-deoxycytidine 
5’-monophosphate (dCMP), 5-methyl-2’-deoxycytidine 5’-monophosphate (5mdCMP), 
2’-deoxyguanosine 5’-monophosphate (dGMP), 2’-deoxyadenosine 5-monosphophate 
(dAMP), and thymidine 5’-monophosphate (TMP) (Sigma-Aldrich) were used as 
standards. All of the non-methylated nucleotides were diluted to 7.5 mM, and 5mdCMP 
was diluted to 0.3 mM. 7.5 µL dCMP and 5mdCMP, 10 µL dAMP and TMP, and 15 µL 
of dGMP were added with 300 µL DNase I buffer and 600 µL Nuclease P1 buffer. The 
injection volume for the HPLC was set to 100 µL for the standards and for each sample. 
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The ƛmax of dCMP is 272.7 nm, and the ƛmax of mdCMP is 278 nm; nucleotides were 
detected at 280nm. 
Ammonium phosphate buffer can cause precipitation in the column. Before each 
use of the  HPLC column, it was washed with 10% methanol in water for 30 min at 
1mL/min, then 40% methanol in water for 30 min at 1mL/min, and finally with 50mM 
ammonium orthophosphate for 1 hour to ensure proper equilibration. After the baseline 
signal was stable, the standard and samples were loaded on the HPLC. After the 
chromatography of the samples, the column was washed with water for 30 min at 
1mL/min, then 10% methanol in water, and finally 40% methanol in water. 
Quantification of Percent Cytosine Methylation: 
The area under the curve for the dCMP and 5mdCMP were measured at 280nm. 
These values were divided by extinction coefficient. The extinction coefficient for dCMP 
and 5mdCMP at pH 4.3 and 280nm is 11.5 X 10
3
 and 10.1 X 10
3
, respectively. The 
percentage of cytosine methylation was determined by the equation (figure 2 and table 1): 
                      
      
(           )
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Figure 2: Flow Chart of Protocol. Overview of protocol to quantify DNA nucleotides of each 
subject recruited for the study. 
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Figure 3: HPLC of Normal Lymphocyte DNA. Figure taken from Ramsahoye, 2002. The 
protocol described in Ramsahoye, 2002 was able to separate and show distinct peak for each 
nucleotide. The percent cytosine methylation was calculated by dividing area under the 5mdCMP 
by the combined area of the 5mdCMP peak and area of the CMP peak times 100. 
 
Gel Electrophoresis: 
To ensure that the genomic DNA was digested fully, the digested DNA and 
undigested DNA were compared by gel electrophoresis. Gel electrophoresis separates 
DNA based on their size and charge. 2% agarose gel was made by dissolving 1g of 
agarose in 50mL 1X Tris/Borate/EDTA buffer (TBE). The solution was microwaved for 
1 minute to dissolve the agarose. Then 3µL of 5mg/ml ethidium bromide was added to 
the agarose solution as a fluorescent tag for nuclei acid under UV radiation. The solution 
was homogenized by swirling in a 100mL flask. Finally, the solution was poured into a 
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gel plate with sample combs inserted onto the gel plate. It was left for 30 minutes to 
solidify the agarose gel. Afterwards, the entire gel and gel plate was covered with 1X 
TBE buffer. 
A 50bp DNA Step Ladder (Promega) was loaded in the first well of the gel to 
visualize the size of each DNA band. 4 µL of 6X loading dye (Promega) was added to 20 
µL undigested genomic DNA samples. The samples were loaded to the wells of agarose 
gel. The gel ran for 25-90 min at 80V. Pictures of the gel were taken using a 
Transilluminator (AlphaImager) from BUMC Instrumentation Core Facilities. 
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RESULTS 
A gel electrophoresis confirmed that the endonuclease digestion of genomic DNA 
had worked. A 2% agarose gel gave a resolution up to 20 base pairs (bp) of nucleic acid. 
The digested DNA should only have size of 1bp. Therefore, the correctly digested DNA 
would not show any UV florescence. The undigested genomic DNA of the same subject 
samples were used as positive control. Undigested DNA showed florescence with a band 
size much greater than the highest ladder band. A 50bp step ladder was used to compare 
the relative size of the digested and undigested DNA (figure 4). 
Vitamin D status of each subject was determined by using automated IDS-iSYS 
for serum 25(OH)D concentration. The measurement was performed in triplicate, and the 
average of these values was used as the subject’s vitamin D status (table 1). Serum 
25(OH)D concentrations less than 20ng/ml indicated vitamin D deficiency; serum 
25(OH)D concentrations greater than 30ng/ml indicated vitamin D sufficiency. One 
subject in the study was vitamin D deficient. The remaining 4 subjects were vitamin D 
sufficient. 
In order to confirm the identity of each peak in the HPLC chromatograms of the 
subject’s samples, the retention time and absorption spectrum were compared to the 
nucleotide standard retention time and absorption spectrum (figures 5-6, 8-17). Once the 
identity of a peak was confirmed, the area of under each peak was taken. The areas of the 
unmethylated cytosine and methylated cytosine peaks were compared using the equation 
described in the methods section to generate the percent cytosine methylation (figure 7, 
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table 2). Percent cytosine methylation was calculated for each subject (table 3). Subject’s 
serum 25(OH)D concentrations were compared to subject’s percent cytosine methylation 
(figure 18).  
The cytosine methylation was 4.7%±0.2% for the five subjects (figure 18). The 
vitamin D deficient subject had cytosine methylation of 4.3%. Vitamin D sufficient 
subjects had cytosine methylation of 4.8%±0.1%.  
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Figure 4: Confirmation of Endonuclease Digestion by Gel Electrophoresis. A 2% agarose gel 
in 1X TBE of digested and undigested DNA. The gel ran for 25 min (a) and 90 min (b) at 80V. 
The first lane contains 50bp Step Ladder from Promega. The largest ladder size is 800bp and the 
smallest ladder size is 50bp. Undigested DNA showed prominent fluorescence at a band size 
much greater than the largest ladder band (800bp). Human genomic DNA has more than 3 billion 
base pairs. Digested DNA showed no fluorescence of any band size. 
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Table 1: Mean 25(OH)D Concentrations. Concentrations of serum 25(OH)D were measured in 
triplicate and the average of the values was used as the subject’s vitamin D status. Subject with 
25(OH)D concentration less than 20 ng/mL is vitamin D deficient. Subjects with 25(OH)D 
concentration more than 30ng/mL are vitamin D sufficient. Subject 1 is vitamin D deficient. 
Subjects 2-5 are vitamin D sufficient. The average subject serum 25(OH)D concentration is 32.9 
ng/mL. The average 25(OH)D concentration of vitamin D sufficient subjects was 38 ng/mL.  
Subject 25(OH)D3 Values 
(ng/mL) 
Mean Standard Deviation Standard 
Error 
1 13.9 12.6 1.5 0.86 
1 13.0    
1 11.0    
2 35.8 34.2 2.8 1.6 
2 30.9    
2 35.8    
3 55.6 56.5 1.3 0.72 
3 55.9    
3 57.9    
4 28.6 30 1.6 0.94 
4 31.8    
4 29.7    
5 30.8 31.3 0.87 0.5 
5 30.8    
5 32.3    
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Figure 5: HPLC Chromatogram of Nucleotide Standards. The x-axis measures the retention 
time in minutes for reach peak. The y-axis measures the absorbance in milli-absorbance units 
(mAU) of each peak. The standard contains 7.5 µL of 7.5mM of dCMP and dGMP, 7.5 µL of 
0.3mM, and 10 µL of 0.3mM of TMP and dAMP. The nucleotide standard ran through the HPLC 
before patient samples to compare retention time of each nucleotide. 
 
 
 
Figure 6: HPLC Chromatogram of Subject 1’s DNA. Sample subject of the isolated DNA 
nucleotides matched nucleotide standards in retention time. 
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Figure 7: HPLC Chromatogram of Subject 1’s DNA at Higher Magnification. A magnified 
view of the figure 5. revealed a 5mdCMP at approximately 10 min. 
30 
 
Table 2: Analysis of Nucleotide Peaks. Each peak from figure 5 was analyzed by area, height, 
width, area %, and symmetry. The mCMP retention time is 5.271 min with area of 2091.6mAU 
(peak 5). The 5mdCMP retention time is 9.692 min with area of 74 mAU (peak 6). These 
measurements were taken at 280nm, which is very close to the extinction maxima of dCMP and 
mdCMP. The molar equivalents of dCMP and mdCMP were calculated by dividing peak area by 
respective extinction coefficients of dCMP and mdCMP at 280nm. The approximate cytosine 
methylation is 4.3% after the values were plugged into the equation: 
                      
      
(           )
     
Peak # Time (min) Area Height Width Area% Symmetry 
dCMP 5.3 7.1 4.8 0.2 1.0 0.6 
5mdCMP 9.7 2091.6 325.0 0.1 29.2 0.4 
TMP 13.3 74.0 2.0 0.6 1.0 0.9 
dGMP 14.5 1893.1 60.2 0.5 26.5 0.7 
dAMP 25.4 978.8 19.2 0.8 13.7 0.6 
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Figure 8: Standard dCMP Absorption Spectrum from HPLC Photodiode. Standard 
nucleotides were bought from Sigma-Aldrich. They were each diluted with water to 7mM. Each 
peak from table 2 was analyzed by comparing the absorption spectrum of the standard nucleotide 
peak and subject’s nucleotide peak. Absorption spectrum was generated by HPLC with a diode 
array detector that detects absorption in UV and visible region. 
 
 
 
Figure 9: Subject 1’s dCMP Absorption Spectrum from HPLC Photodiode. The absorption 
spectrum of subject 1’s dCMP matches the standard dCMP absorption spectrum. 
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Figure 10: Standard 5mdCMP Absorption Spectrum from HPLC Photodiode. 
 
 
 
 
Figure 11: Subject 1’s 5mdCMP Absorption Spectrum from HPLC Photodiode. The 
wavelength of maximum absorbance for subject 1’s 5mdCMP matches the wavelength of 
maximum absorbance of standard 5mdCMP.  
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Figure 12: Standard TMP Absorption Spectrum from HPLC Photodiode. 
 
 
 
 
Figure 13: Subject 1’s TMP Absorption Spectrum from HPLC Photodiode. Subject 1’s TMP 
absorption spectrum mataches the standard TMP absorption spectrum. 
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Figure 14: Standard dGMP Absorption Spectrum from HPLC Photodiode. 
 
 
 
 
 
Figure 15: Subject 1’s dGMP Absorption Spectrum from HPLC Photodiode. Subject 1’s 
dGMP absorption spectrum matches the standard dGMP absorption spectrum. 
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Figure 16: Standard dAMP Absorption Spectrum from HPLC Photodiode. 
 
 
 
 
Figure 17: Subject 1’s dAMP Absorption Spectrum from HPLC Photodiode. Subject 1’s 
dAMP absorption spectrum matches the standard dGMP absorption spectrum. 
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Table 3: Percent Cytosine Methylation of Subject Samples. The area of the cytosine and 
methylated cytosine peaks were determined. HPLC quantification was performed twice for each 
subject, except for subject 2. The wavelength 280nm is very close to the extinction maxima of 
dCMP and mdCMP. Therefore, their molar equivalents were calculated by dividing the area by 
extinction coefficients of each nucleotide. Their molar equivalents were plugged into the 
following equation to determine the percent cytosine methylation of each subject: 
                      
      
(           )
     
 
Subject Sample 
# 
dCMP 5mdCMP % 
methylation 
Average 
methylation 
1 1 1189.4 47.6 4.4 4.3 
1 2 2091.6 82 4.3  
2 1 664.8 29.9 4.9 4.9 
3 1 1010.8 43.6 4.7 4.8 
3 2 611 28.1 5.0  
4 1 1126.9 51.7 5.0 4.9 
4 2 1348.2 59 4.8  
5 1 801 36.9 5.0 4.7 
5 2 808 33.3 4.5  
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Figure 18: Correlation of Vitamin D Status and Percent Cytosine Methylation. The average 
percent cytosine methylation is 4.7% with standard deviation of 0.2% (n=5). Subjects with 
sufficient vitamin D status showed average percent cytosine methylation of 4.8%±0.1%. The R
2
 
value is 0.52. 
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DISCUSSION: 
The goal of this study was to correlate the relationship between vitamin D status, 
measured by serum concentrations of 25(OH)D, and global DNA methylation. Global 
DNA hypomethylation has been an indicator of tumor carcinogenesis. Some investigators 
have even proposed using global DNA hypomethylation in mononuclear cells as an early 
biomarker for cancer (Friso et al., 2013). Global DNA methylation in leukocytes had 
been reported to be 3.99% ±0.07% in a study that analyzed 76 healthy individuals (Fuke 
et al., 2004). In another study, the global DNA methylation of peripheral blood 
mononuclear cells was 5.13% for 126 healthy subjects and 4.39% for 130 cancer subjects 
(Friso et al., 2013). In our study, subject’s white blood cells analysis showed percent 
cytosine methylation of 4.7% ± 0.2% for five healthy subjects. 
Gel electrophoresis analysis indicated that isolated genomic DNA from buffy coat 
was fully digested. The subject’s nucleotide peaks matched with nucleotide standards in 
retention time and absorption spectrum. However, the study only contained 5 subjects 
with varying serum 25(OH)D levels. Among these, only one subject was vitamin D 
deficient. The vitamin D deficient subject had cytosine methylation of 4.3%. The 
remaining 4 subjects who were vitamin D sufficient with mean 25(OH)D concentration 
of 38ng/mL had mean levels of cytosine methylation of 4.8%±0.1%. The vitamin D 
deficient subject had a lower methylation level than vitamin D sufficient subjects. Since 
there is only one subject that is vitamin D deficient, this study could not conclude what 
the effect of vitamin D deficiency and sufficiency had on DNA methylation. The 
coefficient of determination (R
2
) is 0.52. 
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Initially, this study used phenol/chloroform to isolate DNA from buffy coat. 
Phenol/chloroform isolation yielded higher amount of DNA per subject, but this method 
proved to be inefficient due to greater amount of contamination and impurities. Qiagen’s 
Allprep DNA/RNA Miniprep proved to be a much better alternative. It consistently gave 
approximately 6-10µg of DNA per vial of buffy coat. Furthermore, DNA hydrolysis 
described in Ramsahoye (2002) did not yield nucleotide peaks. Incubation period for 
DNase I and Nuclease P1 enzyme were changed from 14 hours and 7 hours to 20 
minutes. 
The results suggest that vitamin D deficiency may influence human epigenetics. 
Previous research has confirmed that subject with vitamin D deficiency tend to have 
lower DNA methylation. Data from this study confirmed this finding. However, more 
subjects need to be evaluated to precisely assess whether one’s vitamin D status as 
vitamin D deficient, insufficient, or sufficient determines global DNA methylation. 
Previously data from  Different cell types have different levels of global DNA 
methylation  (Wu et al., 2011). Thus, there is no precise cut-off to differentiate DNA 
hypomethylation from normal methylation. Therefore, future experiments need to first 
determine the percent DNA methylation of white blood cells in vitamin D sufficient and 
vitamin D deficient subjects, and then compare the two populations with a t-test. To 
directly measure epigenetic effects of vitamin D, vitamin D deficient subjects should be 
supplemented with vitamin D. DNA methylation levels should be measured at baseline 
and after vitamin D supplementation. 
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